Patents by Inventor Vladimir L. Katanaev

Vladimir L. Katanaev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Insect corneal type nanocoatings
    Patent number: 12104078
    Abstract: The present invention relates to in vitro nanocoatings based on insect corneal designs and methods for producing such nanocoatings. In particular, the present invention relates to in vitro nanocoatings based on the mixture of the corneal protein retinin, retinin-like protein, or cuticular protein with complementary lipids. Furthermore, the present invention relates to simple methods for producing such nanocoatings from recombinant proteins and commercially available lipids.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: October 1, 2024
    Assignee: Université de Lausanne
    Inventors: Vladimir L. Katanaev, Mikhail Kryuchkov
  • INSECT CORNEAL TYPE NANOCOATINGS
    Publication number: 20210207001
    Abstract: The present invention relates to in vitro nanocoatings with advantageous functionalities based on insect corneal designs and methods for producing such nanocoatings. In particular, the present invention relates to in vitro nanocoatings based on the mixture of the corneal protein retinin, retinin-like protein, or cuticular protein with complementary lipids. Furthermore, the present invention relates to simple methods for producing such nanocoatings from recombinant proteins and commercially available lipids.
    Type: Application
    Filed: May 29, 2019
    Publication date: July 8, 2021
    Inventors: Vladimir L. Katanaev, Mikhail Kryuchkov
  • PYRAZOLE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY
    Publication number: 20210002265
    Abstract: The present invention relates to a novel class of compounds as inhibitors of the Wnt signalling pathway. The best compounds showed potencies in the low micromolar range and high efficacies (>80%) together with good microsomal stability. Furthermore, in vitro characterization of the compounds show promising effects in various anti-cancer assays. Finally, in vivo characterization showed high accumulation in breast tissue.
    Type: Application
    Filed: March 1, 2019
    Publication date: January 7, 2021
    Inventors: Vladimir L. Katanaev, Alexey Koval